Carson Named Vice-Chair of National Melanoma Committee

June 13, 2011

COLUMBUS, Ohio – Dr. William Carson III, a surgical oncologist who also serves as associate director of clinical research for The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, will become the next vice-chair of the SWOG Melanoma Committee.

SWOG, formerly known as the Southwest Oncology Group, is one of the largest National Cancer Institutes who supports cancer clinical trials cooperative groups in the United States. Its primary mission is to improve the practice of medicine in preventing, detecting and treating cancer. Since 1990, the SWOG Melanoma Committee has conducted 35 studies involving almost 3,500 patients with melanoma and other cutaneous malignancies.

Carson will succeed Dr. Lawrence Flaherty of the Karmanos Cancer Institute in Detroit. As vice-chair, Carson will help develop new clinical trials in melanoma and work to engage new investigators in the cooperative group process both at Ohio State and at other institutions across the United States. Through Carson's selection, Ohio State will become a special member of SWOG and will start enrolling melanoma patients on SWOG clinical trials.

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (cancer.osu.edu) is one of only 40 Comprehensive Cancer Centers in the United States designated by the National Cancer Institute. Ranked by U.S. News & World Report among the top cancer hospitals in the nation, The James is the 205-bed adult patient-care component of the cancer program at The Ohio State University. The OSUCCC – James is one of only seven centers in the country funded by the NCI to conduct both phase I and phase II clinical trials.

# # #

Contact: Jennifer Mutchler, Medical Center Public Affairs and Media Relations, 614-293-3737, or Jennifer.Mutchler@osumc.edu

Contact Media Staff

Amanda Harper

Director of Media Relations


614-685-5420 (direct)


614-293-3737 (main)


Amanda.Harper2@osumc.edu


Media staff are available by calling 614-293-3737 Monday through Friday between 8 a.m. and 5 p.m.

 

If after hours, please call 614-293-8000 (ask the operator to page the hospital administrative manager).

Latest News

New Clinical Trial Aims to Reprogram Cells to Attack a Specific Relapsed Blood Cancer

An upcoming clinical trial at The James aims to reprogram a patient’s immune cells to attack a specific relapsed blood cancer, called multiple myeloma. The idea is to “super-charge” the patient’s immune...

Read More

NCCN Publishes New Guidelines for Smoking Cessation, Effort Led by Ohio State Oncologist

To meet the needs of patients who are smokers at the time of a cancer diagnosis, the National Comprehensive Cancer Network has published smoking cessation guidelines. Ohio State's Peter Shields, MD...

Read More

Molecules in Prostate Tumors Might Predict Whether RT Can Help Prevent Recurrence

A new study has identified a group of molecules in prostate-cancer cells that doctors might one day use to distinguish which patients should be treated with radiation therapy if rising PSA levels...

Read More